ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.605,41
0,09%
S&P 500
5.307,08
0,04%
US Dollar vs BRL
5,1567
-0,32%
Bitcoin
67.955,16
-2,07%
Brent Oil
83,67
1,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aptinyx Inc (APTX)

  7. Aptinyx Inc (APTX) Notícias

APTX

Aptinyx (APTX)

Aptinyx Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:APTX
DataHoraFonteTítuloCódigoCompanhia
21/12/202312:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTXAptinyx Inc
27/06/202315:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
24/05/202317:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
24/05/202317:44Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APTXAptinyx Inc
23/05/202309:26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:APTXAptinyx Inc
15/05/202317:46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:APTXAptinyx Inc
11/05/202309:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
28/04/202317:19Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APTXAptinyx Inc
30/03/202317:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTXAptinyx Inc
30/03/202317:05Business WireAptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic AlternativesNASDAQ:APTXAptinyx Inc
27/02/202318:03Business WireAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate UpdateNASDAQ:APTXAptinyx Inc
31/01/202309:47Business WireAptinyx to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:APTXAptinyx Inc
05/01/202318:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
12/12/202208:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
10/11/202209:45Business WirePreclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for NeuroscienceNASDAQ:APTXAptinyx Inc
10/11/202201:26TipRanksSVB Securities Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
09/11/202212:16TipRanksBMO Capital Remains a Buy on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
08/11/202218:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTXAptinyx Inc
08/11/202218:05Business WireAptinyx Reports Third Quarter 2022 Financial Results and Recent HighlightsNASDAQ:APTXAptinyx Inc
03/11/202208:30Business WireClinical Evaluation of Aptinyx's NYX-783 for Treatment of Opioid Use Disorder to Be Funded by $5.6 Million NIH GrantNASDAQ:APTXAptinyx Inc
18/10/202208:45Business WireAptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022NASDAQ:APTXAptinyx Inc
25/08/202208:30Business WireAptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy BodiesNASDAQ:APTXAptinyx Inc
12/08/202208:15Business WireAptinyx Reports Results from Phase 2b Study of NYX-2925 in FibromyalgiaNASDAQ:APTXAptinyx Inc
05/08/202209:38TipRanksBMO Capital Sticks to Its Buy Rating for Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
04/08/202217:05Business WireAptinyx Reports Second Quarter 2022 Financial Results and Recent HighlightsNASDAQ:APTXAptinyx Inc
02/08/202223:35TipRanksSVB Securities Maintains a Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
15/07/202208:47Business WireAptinyx to Report Second Quarter 2022 Financial Results on Thursday, August 4, 2022NASDAQ:APTXAptinyx Inc
24/06/202215:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APTXAptinyx Inc
22/06/202208:47Business WireAptinyx to Participate in H.C. Wainwright 1st Annual Mental Health ConferenceNASDAQ:APTXAptinyx Inc
23/05/202207:29TipRanksH.C. Wainwright Thinks Aptinyx’s Stock is Going to RecoverNASDAQ:APTXAptinyx Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:APTX

Seu Histórico Recente

BIT
UB358K
UniCredit Bank
TSXV
SCPO.UN
Starlight US Multi Famil...
BIT
P1UCF4
NLBNPIT1UCF4 20991231 17...
ASX
SGRKOC
CSE
PHOS
First Phosphate
BIBX
ROCKIUSDT
ROCKI
OKEX
NEOUSDT
NEO
LSE
STWT
Ls -1x Twitter
ASX
AMPSSJ
LSE
0FCT
Masterflex
BIT
P1ZVK3
NLBNPIT1ZVK3 20991231 93...
ASX
AYH
BITMOT
812431
Citigroup Gm Mc Ap25 Usd
BIT
UB8PEJ
Unicredit Bank
BIT
UB22FP
UniCredit Bank
NASDAQ
AINV
Apollo Investment
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados